DRUG dividend yield: 4.00%. VYM dividend yield: 2.91%. DRUG is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in DRUG shares. VYM tracks the FTSE High Dividend Yield Index, holding ~450 large-cap US companies with above-average dividend yields. With an ultra-low 0.06% expense ratio, it's one of the cheapest dividend ETFs available. Excellent core holding for long-term dividend growth investors seeking broad diversification and reliable income.
DRUG is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in DRUG shares.
VYM tracks the FTSE High Dividend Yield Index, holding ~450 large-cap US companies with above-average dividend yields. With an ultra-low 0.06% expense ratio, it's one of the cheapest dividend ETFs available. Excellent core holding for long-term dividend growth investors seeking broad diversification and reliable income.
Is DRUG or VYM better for dividend income in 2026?
DRUG currently offers a 4.00% yield (2.00/share/year) while VYM offers 2.91% (3.44/share/year). DRUG provides higher current income. However, VYM has grown its dividend faster (7.8% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in DRUG vs VYM earn per year?
With $10,000 invested today: DRUG pays approximately $400/year. VYM pays approximately $291/year. With DRIP reinvestment over 10 years, these grow to $899/year (DRUG) and $785/year (VYM).
Does DRUG or VYM pay monthly dividends?
DRUG pays quarterly dividends. VYM pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬
Get this DRUG vs VYM comparison by email
Save your analysis + get weekly dividend insights. Free forever.